TOP HEADLINES

Featured Story

  • GSK adding 2-D barcode to 4-in-1 flu vaccine packaging

    GSK will begin adding 2-D barcodes to its Fluarix Quadrivalent 4-in-1 influenza vaccine, which the FDA cleared for shipping on Monday. Over the next 6 months GSK will add the barcode technology to the packaging of more vaccines.

Researchers aim at trial to test whether BCG vaccine cuts risk of allergies

Researchers have linked rising allergy rates to improved hygiene and asked whether the Bacillus Calmette-Guérin vaccine can reverse the trend. Existing data is inconclusive, but an Australian team has seen enough to run a 1,400-person trial into the effect of the vaccine.

Study reconfirms safety of flu vaccine in pregnant women

Research in the journal Obstetrics and Gynecology found that 74,000 pregnant women who received a flu shot, in any trimester, were no more likely to experience pregnancy complications.

Incredulity turns to praise as malaria vaccine posts positive PhI data

Sanaria has spent the past decade harvesting parasites from the salivary glands of mosquitoes to use in malaria vaccines. The resulting vaccine uses a weakened form of the whole parasite to generate an immune response.

PharmAthene to add antibody assets in Theraclone merger

PharmAthene said the combined company will have four clinical-stage products, giving it the diversified portfolio desired by management.

Flu vaccine tablet developer raises $20M

The approval of MedImmune's nasally-administered FluMist in 2003 was the first major advance in the delivery of influenza vaccines since immunization against the flu began in 1945. This week Vaxart raised $20 million to bring about the next step forward--vaccines in tablet form.

MORE NEWS

From Our Sister Sites

FierceMarkets Network
FiercePharma Manufacturing
Merck added workers at Ireland plant despite drop in profits

Merck is cutting back its manufacturing footprint and thus its workforce worldwide. In Ireland, which has suffered from some of that contraction, the company's fortunes are followed closely. But a new report to the government there shows that it actually grew employment at a plant in Swords in spite of falling profits.

FierceBiotech
Ex-Shire exec takes helm at startup Sage Therapeutics

Sage Therapeutics has recruited pharmaceutical veteran Dr. Jeffrey Jonas as CEO in a hiring drive that adds decades of industry experience at the two-year-old startup.